HEATH SKINNER to Erlotinib Hydrochloride
This is a "connection" page, showing publications HEATH SKINNER has written about Erlotinib Hydrochloride.
Connection Strength
0.032
-
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer. PLoS One. 2016; 11(6):e0156910.
Score: 0.032